{
    "study_accession": "SDY1092",
    "actual_completion_date": "2013-01-07",
    "actual_enrollment": 10,
    "actual_start_date": "2012-02-28",
    "age_unit": "Years",
    "brief_description": "Whole blood RNA-Seq was applied to investigate gene expression kinetics in Tanzanian males who underwent controlled malaria infection by intradermal injection with aseptic, purified, cryopreserved Plasmodium falciparum sporozoites.",
    "brief_title": "Transcriptional responses induced by controlled human malaria infection (CHMI)",
    "clinical_trial": "Y",
    "condition_studied": "Controlled Human Malaria Infection",
    "dcl_id": 2,
    "description": "Whole blood RNA-Seq was applied to investigate gene expression kinetics in Tanzanian males who underwent controlled malaria infection by intradermal injection with aseptic, purified, cryopreserved Plasmodium falciparum sporozoites.  Building on PfSPZ challenge study: ClinicalTrials.gov Identifier: NCT01540903, PUBMED:PMC4155546",
    "doi": "10.21430/M32AARFE8U",
    "endpoints": "Completion of whole blood RNA-Seq analyses.",
    "gender_included": "Male",
    "hypothesis": "CHMI induces gene expression changes in Tanzanian adults.",
    "initial_data_release_date": "2019-01-16",
    "initial_data_release_version": "DR29",
    "intervention_agent": "Aseptic, purified, cryporeserved Plasmodium falciparum sporozoites",
    "latest_data_release_date": "2019-01-16",
    "latest_data_release_version": "DR29",
    "maximum_age": "  27.20",
    "minimum_age": "  20.70",
    "objectives": "Characterize gene expression changes in Tanzanian adults induced by CHMI.",
    "official_title": "Transcriptional responses induced by controlled human malaria infection (CHMI)",
    "sponsoring_organization": "NIAID",
    "target_enrollment": 10,
    "workspace_id": 2517,
    "research_focus": [
        "Infection Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM3836",
            "description": "Volunteers injected intradermally with a total of 25'000 infectious Plasmodium falciparum sporozoites (PfSPZ).",
            "name": "High Dose Group"
        }
    ],
    "personnel": [
        {
            "first_name": "Stephen",
            "last_name": "Hoffman",
            "organization": "Sanaria Inc.",
            "role_in_study": "Principal Investigator",
            "site_name": "Bagamoyo Clinical Trial Unit (BCTU) of the Ifakara Health Institute (IHI)"
        }
    ],
    "pubmed": [
        {
            "title": "Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites.",
            "journal": "Am J Trop Med Hyg.",
            "month": "Sep",
            "year": "2014",
            "doi": "10.4269/ajtmh.14-0119. Epub 2014 Jul 28.",
            "pubmed_id": "25070995"
        }
    ],
    "program": [
        {
            "program_name": "Human Immunology Project Consortium (HIPC) RFA-AI-14-007",
            "contract_name": "Immune Profile and Network Analysis of Malaria Infection and Vaccination"
        }
    ],
    "assay": [
        {
            "measurement_technique": "RNA sequencing",
            "number_of_expsamples": 40
        }
    ],
    "subject": {
        "race": [
            {
                "race": "Black or African American",
                "count": 10
            }
        ],
        "gender": [
            {
                "Male": 10
            }
        ]
    }
}
